SREBF1 and metabolic dysfunction-associated steatotic liver disease: Our studies reinforce AMPK as a direct upstream kinase that phosphorylates SREBP-1c to inhibit its nuclear translocation and transcriptional activity, ultimately suppressing hepatocyte lipogenesis and INSR degradation implicated in the rescuing from NAFLD and insulin resistance.